First Read Cardinal Health Inc First Take: Improved FY25 Guidance and LT Commitment to GMPD Conveyed Loaded Print: Improved FY25 Guide, Steady GMPD Outlook and More Aggressive Repos Should Buoy Sentiment Along with F4Q results, CAH tweaked preliminary FY25 financial expectations offered last quarter. Key guidance highlights include: (1) FY25 EPS range of $7.55-7.70 (prior: at least $7.50) on better Pharma EBIT growth of +1-3% ( prior: at least 1% - at midpoint adds ~$0.06); (2) lower interest and other (at ...

Cardinal Health Inc. (NYSE:CAH) Q4 2024 Earnings Conference Call August 14, 2024 8:30 AM ET Company Participants Jason Hollar - Chief Executive Officer Aaron Alt - Chief Financial Officer Matt Sims - Vice President, Investor Relations Conference Call Participants Lisa Gill - JP Morgan Eric Percher - Nephron Research Michael Cherny - Leerink Partners Erin Wright - Morgan Stanley Allen Lutz - Bank of America Kevin Caliendo - UBS Eric Coldwell - Baird George Hill - Deutsche Bank Anna Grasinsky - Barclays Eliza ...

Key TakeawaysCardinal Health exceeded fourth-quarter earnings and revenue estimates on strong sales of pharmaceuticals.The healthcare firm raised its full-year profit guidance and revenue for its Pharmaceutical and Specialty Solutions unit.Cardinal Health also boosted its share buyback plan. Shares of Cardinal Health (CAH) gained in intraday trading Wednesday as the provider of healthcare services and products posted better-than-anticipated results and raised its outlook on strong drug sales. The company re ...

Cardinal Health, Inc. (CAH) reported fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of $1.84, which beat the Zacks Consensus Estimate of $1.72 by 7%. The bottom line also improved 29% year over year.GAAP EPS in the quarter was 96 cents against a loss of 22 cents per share in the year-ago period.Revenue DetailsSales improved 12% on a year-over-year basis to $59.9 billion. The top line also beat the Zacks Consensus Estimate by 2%.Segmental AnalysisPharmaceutical and Specialty Solutions SegmentIn ...

Cardinal Health Inc (NYSE:CAH) stock is gapping higher on the charts today, after the company announced strong fiscal fourth-quarter results and raised its full-year guidance. Plus, the Ohio-based healthcare name raised its share repurchase expectations for fiscal 2025 to a total of $750 million. At last glance, CAH was up 3.6% at $106.31, earlier as high as $109. This positive price action has the stock flipping above the $105 level, which has provided pressure since April, as well as its 200-day moving av ...

For the quarter ended June 2024, Cardinal Health (CAH) reported revenue of $59.87 billion, up 12% over the same period last year. EPS came in at $1.84, compared to $1.55 in the year-ago quarter.The reported revenue represents a surprise of +1.95% over the Zacks Consensus Estimate of $58.72 billion. With the consensus EPS estimate being $1.72, the EPS surprise was +6.98%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine thei ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 1-11373 Cardinal Health, Inc. (Exact name of registrant as specified in its charter) Ohio 31-0958666 (State or othe ...

Cardinal Health (CAH) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.72 per share. This compares to earnings of $1.55 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6.98%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $1.95 per share when it actually produced earnings of $2.08, delivering a surprise of 6.67%.Over the last four qua ...

Q4 FY24 Earnings Cardinal Health, Inc. August 14, 2024 © 2024 Cardinal Health. All Rights Reserved. 1 © 2024 Cardinal Health. All Rights Reserved. INTERNAL USE ONLY • Q4 FY24 Earnings Cautions Concerning Forward-Looking Statements This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "wi ...

As of Aug 14, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to ...